Lazard Ltd. (LAZ) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Lazard Ltd. faces increased business risk due to anti-takeover provisions embedded in its organizational structure and reinforced by Delaware law, which may impede mergers and acquisitions. These provisions, including the ability to issue preferred stock and the requirement of unanimous stockholder action for written consent, create significant barriers to potential takeovers. Additionally, the staggered board terms and limitations on stockholder meetings could deter acquisition proposals and may negatively influence the market price of Lazard’s common stock if they are seen to thwart takeover attempts that stockholders might otherwise support.
Overall, Wall Street has a Moderate Buy consensus rating on LAZ stock based on 5 Buys, 1 Sell and 1 Hold.
To learn more about Lazard Ltd.’s risk factors, click here.
